Ligand Pharmaceuticals (LGND) stock jumps premarket as BofA starts its coverage with a Buy rating and a $244 target, citing its business model. Read more here.
Ligand gains new Buy from BofA on high-margin, less risky narrative
Mar. 11, 2026 9:06 AM ETLigand Pharmaceuticals Incorporated (LGND) StockBy : Dulan Lokuwithana, SA News Editor
Comments
Ligand Pharmaceuticals (LGND) traded higher in the premarket o… [363 chars]
Source: Seeking Alpha | Published: 2026-03-11T13:06:58Z
Credit: Seeking Alpha
